Correspondence 0001437749-23-008044 from cbdMD, Inc. (YCBD)
cbdMD, Inc.
Date: March 27, 2023 · CIK: 0001644903 · Accession: 0001437749-23-008044
AI Filing Summary & Sentiment
File numbers found in text: 333-270502
Show Raw Text
CORRESP 1 filename1.htm ycbd20230323_corresp.htm cbdMD, Inc. 8845 Red Oak Boulevard Charlotte, North Carolina 28217 Writer’s Direct Line (919) 641-8759 'CORRESP' March 27, 2023 Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street N.E. Washington, DC 20549 Attention: Benjamin Richie Division of Corporation Finance Office of Industrial Applications and Services Re: cbdMD, Inc. (the "Company") Registration Statement on Form S-1 Filed March 13, 2023 File No. 333-270502 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to Wednesday, March 29, 2023, at 5:00 p.m., Eastern time, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Securities Act. Once the Registration Statement is effective, please orally confirm the event with our counsel Nason, Yeager, Gerson, Harris & Fumero, P.A. by calling Brian Pearlman, Esq. at (954) 880-9484. Thank you. Sincerely, /s/ T. Ronan Kennedy T. Ronan Kennedy Interim Chief Executive Officer and Chief Financial Officer cc: Brian Pearlman, Esq., Nason Yeager Gerson Harris & Fumero, P.A. Brian Bernstein, Esq., Nason Yeager Gerson Harris & Fumero, P.A.